In an NCI study, an alternative treatment regimen called dose-adjusted EPOCH-R that is less toxic than standard dose-intensive chemotherapy was highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.
from NCI News Releases https://ift.tt/2ZEcLH1
from NCI News Releases https://ift.tt/2ZEcLH1